Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the body’s largest arteries with an endovascular graft delivered during a minimally invasive procedure without blocking a critical artery. The Zenith® Branch Endovascular Graft-Iliac Bifurcation from Cook Medical, approved today by Health Canada’s Medical Devices Bureau, is specifically designed to preserve flow to the internal iliac artery allowing for the endovascular treatment of both aortoiliac and iliac artery aneurysms that commonly occur in patients with abdominal aortic aneurysms (AAA). Aneurysms are bulges in the walls of the major arteries that left untreated can rupture causing death.
“Aortoiliac and iliac aneurysms are known to be particularly difficult to treat due to the tortuous anatomy,” said Dr. Cherrie Abraham of Jewish General Hospital in Montreal. “The control and stability of Cook’s branch graft offers precise deployment. The capability to preserve blood flow to the internal iliac artery is a crucial benefit, too, as it will help avoid complications that can arise from internal iliac embolization.”
The Cook branch graft is bifurcated, like the iliac artery itself, with openings to connect the common iliac, side branch (internal iliac) and external iliac segments. Built on Cook’s proven Zenith technology, which has been used for years in the endovascular treatment of aneurysms in other major vessels, the device preserves flow to the iliac artery, reducing the potential for complications such as colon ischemia, buttock and hip claudication or impairment, and impotence.